Glaxosmithkline Pharmaceuticals Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Mar '25
    Dec '24
    Sep '24
    Jun '24
    Mar '24
    Total Qtr Revenue cr
    1,015.05
    984.49
    1,045.31
    850.29
    959.63
    Other Income Qtr Cr40.6835.0734.5435.6429.83
    Operating Revenues Qtr974.37949.421,010.77814.65929.80

    *All values are in Cr.

    Operating Expenses Qtr
    641.18
    657.50
    689.06
    584.11
    672.54
    Operating Profit Qtr
    333.19
    291.92
    321.71
    230.54
    257.26
    EBITDA Qtr Cr
    373.87
    326.99
    360.94
    266.18
    289.49
    Depreciation Qtr
    14.72
    18.80
    16.86
    16.41
    18.10
    Net Profit Qtr
    262.87
    229.88
    252.50
    182.33
    194.48
    Basic EPS Qtr
    15.52
    13.57
    14.91
    10.76
    11.37
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -